研究会・学会発表

◆Real-world efficacy of isatuximab, carfilzomib, and dexamethasone in RRMM: KMF database analysis 近畿大学　芹澤 憲太郎先生

◆Renal function and its variable prognostic importance in NDMM – Kansai Myeloma Forum retrospective analysis – 若草第一病...

◆Predicting efficacy of isatuximab + pomalidomide for multiple myeloma by lymphocyte/monocyte ratio京都大学　島津 裕先生

◆Impact of Renal Function on Initial Therapy and Outcomes in Transplant-ineligible Multiple Myeloma Patients 　 京都大学...

◆The Effect of Elotuzumab Deteriorates after Daratumumab: A Multicenter Retrospective Study 京都大学　中村 直和先生

◆Outcomes of VRD induction followed by ASCT or not – Kansai Myeloma Forum retrospective analysis -　大阪公立大学　高桑 輝人先生

◆Updated real-world data of 2572 patients with symptomatic myeloma registered in Kansai Myeloma Forum　京都府立医科大学　志村 勇司先生 ...

◆Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM:A retrospective analysis from KMF　京都鞍馬口医療センター  淵田真一先...

◆Significance of maintenance therapies in symptomatic multiple myeloma patients with HDT/ASCT関西医科大学　中谷　綾

◆Induction therapies for transplant-ineligible NDMM: retrospective analysis of 547 cases from KMF database.京都府立医科大学　志村勇...